Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer

Published:2018-03 Issue:3 Volume:148 Page:553-558
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Kessous Roy,Octeau David,Klein Kathleen,Tonin Patricia N.,Greenwood Celia M.T.,Pelmus Manuela,Laskov Ido,Kogan Liron,Salvador Shannon,Lau Susie,Yasmeen Amber,Gotlieb Walter H.^ORCID

Funder

AstraZeneca Canada

Israel Cancer Research Fund

Gloria's Girls

The Anne-Marie and Mitch Garber Fund

Susan and Jonathan Wener Fund

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference26 articles.

1. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin;Seidman;Int. J. Gynecol. Pathol.,2004

2. Integrated genomic analyses of ovarian carcinoma;Network CGAR;Nature,2011

3. Prognostic factors for stage III epithelial ovarian cancer: a gynecologic oncology group study;Winter;J. Clin. Oncol.,2007

4. Direct upregulation of STAT3 by microRNA-551b-3p deregulates growth and metastasis of ovarian cancer;Chaluvally-Raghavan;Cell Rep.,2016

5. UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy;Zhang;Cancer Chemother. Pharmacol.,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations in the expression of homologous recombination repair (HRR) genes in breast cancer tissues considering germline BRCA1/2 mutation status;Breast Cancer Research and Treatment;2024-07-30

2. Resistance prediction in high‐grade serous ovarian carcinoma with neoadjuvant chemotherapy using data‐independent acquisition proteomics and an ovary‐specific spectral library;Molecular Oncology;2023-03-19

3. Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges;Frontiers in Oncology;2022-07-26

4. Efficacy and Safety of PARP Inhibitor Combination Therapy in Recurrent Ovarian Cancer: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2021-08-13

5. Basic and Preclinical Research for Personalized Medicine;Journal of Personalized Medicine;2021-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3